Trend Analysis and Forecasting Study on the Changing Disease Burden of Rheumatoid Arthritis in China, 1990-2021

作者
LING Yao, ZHANG Wenbin, WANG Shihong, CHEN Yongze, DONG Wenjiao, DENG Xingyu, DING Yuanlin
出处
期刊:DOAJ: Directory of Open Access Journals - DOAJ 被引量:3
标识
DOI:10.12114/j.issn.1007-9572.2024.0284
摘要

Background Rheumatoid arthritis (RA) is a common chronic autoimmune disease, the treatment and care of which requires long-term investment, including drug therapy, surgical treatment and rehabilitation, etc., which imposes heavy economic and social burdens on the patient's family and the society, and an analysis of the trend of change in the burden of disease and the prediction of the burden of disease can provide references for the formulation of relevant prevention and treatment strategies. Objective To understand the changes in the burden of disease of RA in China from 1990 to 2021 and to predict the incidence, prevalence, and disability adjusted life years (DALYs) rates of RA in China from 2022 to 2042. Methods Burden of disease indicators such as DALYs, incidence and prevalence of RA from the Global Burden of Disease Study 2021 (GBD 2021) were extracted for the years 1990-2021, and the rate of change and estimated annual percentage change (EAPC) were calculated using SPSS 27.0, respectively. The autoregressive sliding average model (ARIMA) was used to project the incidence, prevalence and DALYs rates for 2022-2042. Results In 2021, the incidence, prevalence and DALYs rate of RA in China were 17.38/100 000, 334.25/100 000 and 58.61/100 000, respectively, which were 59.89%, 92.61% and 71.07% higher than those in 1990, and the incidence, prevalence and DALYs rate of RA in China showed an increasing trend between 1990-2021, with an EAPC 1.61%, 2.33% and 2.02%, respectively (P<0.05). The rates of incidence, prevalence, and DALYs in women were 22.55/100 000, 460.19/100 000, and 78.25/100 000, which in men were 12.45/100 000, 214.09/100 000, and 39.87/100 000 in 2021. In 2021, China's RA incidence reached its highest in the age group of 75-79 years (34.37/100 000), the prevalence in the 80 years old and above reached the highest (836.13/100 000), and the rate of DALYs was highest in the age group of 80 years old and above (223.81/100 000). The results of the ARIMA model showed that the incidence rate of RA in China was projected to be 20.26/100 000, the prevalence rate to be 468.60/100 000, and the rate of DALYs to be 82.09/100 000 in 2042, in which the incidence rate had increased by 15.57%, the prevalence rate and the rate of DALYs had increased by 37.94% and 37.90% respectively from the 2022 level, and there were significant age differences. Conclusion There is a clear trend of increasing disease burden of RA in China from 1990 to 2021, with age and gender differences. Incidence, prevalence and DALYs due to RA are expected to continue to rise by 2042. This suggests that the RA in China should implement appropriate primary and secondary prevention measures for key populations such as the elderly and menopausal women.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CodeCraft的应助被吴111采纳,获得10
1秒前
1秒前
瘦瘦稀完成签到,获得积分10
1秒前
CarryLJR的应助被薛雨佳采纳,获得10
2秒前
之之怪发布了新的文献求助50
2秒前
驰驰发布了新的文献求助10
3秒前
linhongwei完成签到,获得积分20
4秒前
4秒前
5秒前
大宝鼠完成签到,获得积分10
5秒前
lq发布了新的文献求助10
6秒前
可口可乐发布了新的文献求助10
6秒前
7秒前
kk发布了新的文献求助10
8秒前
8秒前
ling发布了新的文献求助10
9秒前
10秒前
10秒前
10秒前
liu完成签到 ,获得积分10
11秒前
小陈发布了新的文献求助10
11秒前
11秒前
12秒前
标致鹤轩完成签到,获得积分10
12秒前
TFoCR7发布了新的文献求助10
13秒前
琱琱完成签到,获得积分10
13秒前
凉茶无语完成签到,获得积分10
13秒前
molihuakai的应助被瀛洲晚风采纳,获得10
14秒前
14秒前
宾利的姐姐关注了科研通微信公众号
14秒前
14秒前
15秒前
15秒前
Orange的应助被长情的小鸽子采纳,获得10
15秒前
顺利曼易完成签到,获得积分10
15秒前
15秒前
16秒前
闹肚不赌屁完成签到,获得积分20
16秒前
米米发布了新的文献求助10
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178695
求助须知:如何正确求助?哪些是违规求助? 9569449
关于积分的说明 21804643
捐赠科研通 7773744
什么是DOI,文献DOI怎么找? 3432903
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478500